• The prototype of the film "Dying to Survive"

• The "first person" introduced Indian anti-cancer generic drugs，whose case had driven the rapid development of China's generic drug policy.

• In April 2018, the "Opinions of the General Office of the State Council on Reforming and Improving the Supply Guarantee and Use Policy of Generic Drugs" was officially issued.

• Northeastern University MBA (Finance) in the United States.

• Leeds University International Marketing (Master's), UK.

• Shenyang Pharmaceutical University, majoring in Pharmacy, Master's degree.

• Vice Chairman of the Intelligent Manufacturing Professional Committee of Traditional Chinese Medicine of the China Association of Traditional Chinese Medicine.

• Outstanding Chief Talent Officer of the China Talent Development Award.

• Vice President of Yunnan Youth Entrepreneurs Association.

• The 9th Yunnan Provincial Excellent Private Entrepreneurs.

• 2001-2003: Hunan Xiaoxiang Morning Post was awarded the title of "exemplary individual" by the newspaper office and Hunan News Publishing Group.

• 2003-2007: Director of the Advertising Economic Information Center of Shanghai Youth Daily.

• 2007-2016: Senior Vice President, Beijing Shitong Warner Media Group.

• 2017-present: Chairman of Beijing Muyun Mountain Housing Culture Co., Ltd., investing in the establishment of a private museum - Beijing Tangga Art Museum.

• In 2018, joined the China Youth Entrepreneurs Association of the Central Committee of the Communist Youth League.

• In 2019, Shanghai Rongyu Biomedical Technology Co., Ltd. was established as the chairman.

Dr. SUNILENDU ROY has more than 30 years of experience in drug development. He has worked for Ranbay, Sandoz, Astra, Warner and Zydus Cadila in formulation process research. His developed drugs have been registered in more than 60 countries, including the United States, and he owns more than 20 patents. More dosage form development and guidance of experience. He takes as Senior R&D Consultant of Longjin Careyou.

Indian, Master of pharmaceutical formulation, with more than 10 years of drug formulation research technology, completed 30 generic drugs research and development.

He has working experience in India and Malaysia, and has worked in well-known enterprises such as Glenmark generics Limited and Mylan Laboratories Limited. He is now as a senior pharmaceutical formulation scientist of Longjin Careyou.

VIKAS PAYAL, Indian, master of pharmaceutical analysis, and the direction of Chinese pharmaceutical company engaged in pharmaceutical analysis in India 12 years. Since 2017, he has been engaged in the research and development of generic drugs in China, and has worked in the R&D departments of companies such as Chenxin Pharmaceutical and WuXi AppTec. He is now a senior pharmaceutical analysis researcher of Longjin Careyou.